Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 6114
TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50: 1.42nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109278(US8609622, 5)
Affinity DataIC50: 1.49nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 3.31nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50: 3.65nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109279(US8609622, 7)
Affinity DataIC50: 4.58nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 6.35nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 6.92nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109276(US8609622, 3)
Affinity DataIC50: 8.08nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109280(US8609622, 9)
Affinity DataIC50: 9.28nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSodium/glucose cotransporter 2(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109274(US8609622, 1)
Affinity DataIC50: 9.53nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50: 600nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 1.22E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109280(US8609622, 9)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109274(US8609622, 1)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109275(US8609622, 2)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109276(US8609622, 3)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109278(US8609622, 5)
Affinity DataIC50: 2.52E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109277(US8609622, 4)
Affinity DataIC50: 3.55E+3nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent

TargetSGLT1 protein(Mouse)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM109279(US8609622, 7)
Affinity DataIC50: 1.43E+4nMAssay Description:Inhibitory activity of the compounds using SGLT1 and SGLT2.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2014
Entry Details
Go to US Patent